ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 879

Fucosyltransferase 1 (fut1) Is Overexpressed in Rheumatoid Arthritis Synovial Tissue and Modifies Cytokine Production

Takeo Isozaki1, Jeffrey H. Ruth2, M. Asif Amin1, Phillip L. Campbell1, Steven E. Domino3, G. Kenneth Haines III4 and Alisa E. Koch5, 1Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, 2Internal Medicine, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, 3Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, 4Department of Pathology, Yale University, New Haven, CT, 5Internal Medicine - Rheumatology, University of Michigan Medical School, Ann Arbor, MI

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Angiogenesis, chemokines, cytokines, glycoproteins and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, and Gene Regulation

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by inflammation and joint destruction. Angiogenesis and cytokine production are involved in the pathogenesis of RA. We have shown that soluble H and Lewisy antigens are mediators of angiogenesis and are upregulated in the RA joints compared to normal (NL) or osteoarthritis (OA) joints. Fucosyltranseferase 1 (fut1) is an α(1,2)-fucosyltransferase responsible for synthesis of the H blood group and Lewisy antigens. However, a direct role for fut1 in RA has not been demonstrated. In this study, we examined the expression of fut1 in RA synovial tissue (ST) and determined  the functional consequences of fut1 expression.

Methods: Fut1 expression was determined in RA, OA and NL ST samples by immunohistological staining. To determine whether fut1 was expressed by the human microvascular endothelial cell line (HMEC-1) and human dermal microvascular endothelial cells (HMVECs), real time polymerase chain reaction (RT-PCR) was performed. To block the expression of fut1, HMEC-1s and HMVECs were transfected with fut1 sense or antisense oligonucleotides (ODNs). After treatment, cells were stimulated with interleukin-1β (IL-1β), IL-17 or phorbol 12-myristate 13-acetate (PMA) to stimulate cytokine expression. We examined monocyte chemotactic protein (MCP)-1/CCL2 expression as this chemokine has been shown to be decreased in mouse KRN arthritis induced fut1 knockout joints. We also examined angiogenic vascular endothelial growth factor (VEGF) and regulated upon activation and normal T-cell expressed, and secreted (RANTES)/CCL5 expression, as these cytokines have been shown to be important in RA pathogenesis. In addition, we isolated endothelial cells (ECs) from wild type (wt) and fut1 knockout mice. To confirm the role of fut1 in angiogenesis, we performed EC chemotaxis using wt and fut1 knockout ECs in modified Boyden chambers.

Results: RA STs contained a greater percentage of fut1 ECs than did OA or NL STs [mean ± SEM; RA ST (n=18) 34 ± 8%; OA ST (n=18) 14 ± 6% and NL ST (n=18) 11 ± 4%, p<0.05 between RA ST and OA ST; RA ST and NL ST]. To determine if fut1 expression was inducible by inflammatory cytokines, we stimulated ECs with IL-1β and found that fut1 messenger RNA (mRNA) was IL-1β inducible in HMEC-1s and HMVECs.  Fut1 antisense ODN transfected HMEC-1s and HMVECs had significantly decreased expression of MCP-1/CCL2 and RANTES/CCL5 compared to fut1 sense ODN transfected cells stimulated with  IL-1β, IL-17 or PMA at the mRNA and protein levels (p<0.05). Fut1 knockout mouse ECs stimulated with IL-1β expressed less VEGF mRNA than wt ECs (p<0.05). These results indicate that fut1 regulates EC expression of cytokines important in RA pathogenesis. Finally, fut1 knockout mouse ECs had decreased migration to VEGF compared with wt mouse ECs (10 ± 1 vs. 16 ± 1 cells migrated, n=6 experiments, p<0.05).

Conclusion: These data show that fut1 is overexpressed in RA ST, and that by blocking fut1 expression, we can modify the production of many proinflammatory cytokines. In addition, we show that fut1 regulates EC migration, a facet of angiogenesis in response to VEGF. Hence, fut1 may be an important new target for RA therapy.


Disclosure:

T. Isozaki,
None;

J. H. Ruth,
None;

M. A. Amin,
None;

P. L. Campbell,
None;

S. E. Domino,
None;

G. K. Haines III,
None;

A. E. Koch,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fucosyltransferase-1-fut1-is-overexpressed-in-rheumatoid-arthritis-synovial-tissue-and-modifies-cytokine-production/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology